1. Antibacterial therapy in the immunocompromised host;de Pauw, B.E.;Curr Opin Infect Dis,1989
2. Imipenem-cilastatin as initial therapy for febrile cancer patients;Bodey, G.P.; Alvarez, M.E.; Jones, P.G.; Rolston, K.V.; Steelhammer, L.; Fainstein, V.;Antimicrob Agents Chemother
3. Thienamycin: development of imipenem-cilastatin;Kahan, F.M.; Kropp, H.; Sundelof, J.G.; Brinbaum, J.;J Antimicrob Chemother,1983
4. Infections caused by Pseudomonas maltophilia with emphasis on bacteraemia. Case report and a review of the literature;Zuravleff, J.J.; Yu, V.L.;Rev Infect Dis,1982
5. Infections caused by Pseudomonas maltophilia;Muder, R.R.; Yu, V.L.; Dummer, J.S.; Vinson, C.; Lumish, R.M.;Arch Intern Med,1987